Back to search
Myasthaenia Gravis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myasthaenia Gravis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myasthaenia Gravis trials you may qualify forThe AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylc…
The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell…
This study is an open label, single center, prospective, 26 weeks study with descriptive analysis where IVIG is replaced by efgartigimod therapy. MG-ADL and MGQ…
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it…
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
The planned project is an intervention study to assess the risk of falling after adaptation of an assistive gait devices in patients with the following neuromus…
MEK inhibitors (trametinib, cobimetinib, selumetinib or binimetinib) have been used since 2016 to treat metastatic melanoma, by targeting the MAPK pathway Neuro…